Mycobacterium Citations List: May 2024

Literature Citations

1. A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity. Bendi, A., P. Yadav, K. Saini, A. Singh Bhathiwal, and N. Raghav. Chemistry & Biodiversity, 2024. 21(5): p. e202400067. PMID[38500408].
[PubMed]. TB_05_2024.

2. Synthesis of Narrow-spectrum Anti-mycobacterial Molecules Without Effect on the Diversity of Gut Microbiota in Mice Based on the Structure of Rifampicin. Chen, J.X., H.M. Dong, Y.X. Cai, L.X. Tian, and Z.C. Yang. Bioorganic Chemistry, 2024. 146: p. 107282. PMID[38537334].
[PubMed]. TB_05_2024.

3. In Vitro Activity of Cefoxitin, Imipenem, Meropenem, and Ceftaroline in Combination with Vaborbactam against Mycobacterium abscessus. Chen, L., E. Shashkina, N. Kurepina, V. Calado Nogueira de Moura, C.L. Daley, and B.N. Kreiswirth. Antimicrobial Agents and Chemotherapy, 2024. 68(5): p. e0017424. PMID[38557171]. PMCID[PMC11064484].
[PubMed]. TB_05_2024.

4. New Synergistic Benzoquinone Scaffolds as Inhibitors of Mycobacterial Cytochrome bc1 Complex to Treat Multi-drug Resistant Tuberculosis. Chilamakuru, N.B., A.D. Vn, V.B. G, N. Pallaprolu, A. Dande, D. Nair, R.V. Pemmadi, Y.P. Reddy, and R. Peraman. European Journal of Medicinal Chemistry, 2024. 272: p. 116479. PMID[38733886].
[PubMed]. TB_05_2024.

5. Pradimicin U, a Promising Antimicrobial Agent Isolated from a Newly Found Nonomuraea composti sp. nov. Duangupama, T., P. Pittayakhajonwut, C. Intaraudom, C. Suriyachadkun, S. Tadtong, N. Kuncharoen, Y.W. He, S. Tanasupawat, and C. Thawai. Scientific Reports, 2024. 14(1): p. 10942. PMID[38740839]. PMCID[PMC11091084].
[PubMed]. TB_05_2024.

6. Synthesis, Electronic, and Antibacterial Properties of 3,7-Di(hetero)aryl-substituted Phenothiazinyl N-Propyl Trimethylammonium Salts. Khelwati, H., L. van Geelen, R. Kalscheuer, and T.J.J. Müller. Molecules, 2024. 29(9). PMID[38731617]. PMCID[PMC11085201].
[PubMed]. TB_05_2024.

7. Antimycobacterial Potential of Green Synthesized Silver Nano Particles from Selected Himalayan Flora. Mahmood, S., S. Jannat, A.H. Shah, A. Fariq, S. Rasheed, A. Wazeer, S.H. Salmen, M.J. Ansari, and A. Qayyum. Journal of Applied Botany and Food Quality, 2024. 97: p. 54-62. ISI[001211001000001].
[WOS]. TB_05_2024.

8. Synthesis, Molecular Docking Study and Biological Evaluation of New Pyrrole Scaffolds as Potential Antitubercular Agents for Dual Targeting of Enoyl ACP Reductase and Dihydrofolate Reductase. Mahnashi, M.H., S. Avunoori, S. Gopi, I.A. Shaikh, A. Saif, F. Bantun, H.S. Faidah, A.A. Alhadi, J.H. Alshehri, A.A. Alharbi, R.P. S, and S.D. Joshi. Plos One, 2024. 19(5): p. e0303173. PMID[38739587]. PMCID[PMC11090339].
[PubMed]. TB_05_2024.

9. Design, Synthesis and Antimycobacterial Activity of Imidazo[1,5-a]quinolines and their Zinc-complexes. Marner, M., N. Kulhanek, J. Eichberg, K. Hardes, M.D. Molin, J. Rybniker, M. Kirchner, T.F. Schäberle, and R. Göttlich. RSC Medicinal Chemistry, 2024. 15(5): p. 1746-1750. PMID[38784461]. PMCID[PMC11110795].
[PubMed]. TB_05_2024.

10. Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of Mycobacterium tuberculosis. Nantongo, M., D.C. Nguyen, C.R. Bethel, M.A. Taracila, Q. Li, K.M. Dousa, E. Shin, S.G. Kurz, L. Nguyen, B.N. Kreiswirth, W.H. Boom, M.S. Plummer, and R.A. Bonomo. ACS Infectious Diseases, 2024. 10(5): p. 1767-1779. PMID[38619138].
[PubMed]. TB_05_2024.

11. Synthesis, Antibacterial Effects, and Toxicity of Licochalcone C. Ozanique, P.R., A.L. Helena, R.P. Menezes, D.S. Gonçalves, M.B. Santiago, G. Dilarri, J.C.O. Sardi, H. Ferreira, C.H.G. Martins, and L.O. Regasini. Pharmaceuticals, 2024. 17(5). PMID[38794203]. PMCID[PMC11124413].
[PubMed]. TB_05_2024.

12. Synthesis, Activity, Toxicity, and In Silico Studies of New Antimycobacterial N-Alkyl Nitrobenzamides. Pais, J.P., O. Antoniuk, D. Pires, T. Delgado, A. Fortuna, P.J. Costa, E. Anes, and L. Constantino. Pharmaceuticals, 2024. 17(5). PMID[38794178]. PMCID[PMC11124399].
[PubMed]. TB_05_2024.

13. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques. Sadineni, K., S. Reddy Basireddy, T. Rao Allaka, S. Yatam, S. Bhoomandla, V. Muvvala, and S. Babu Haridasyam. Chem Biodivers, 2024. 21(5): p. e202400389. PMID[38457745].
[PubMed]. TB_05_2024.

14. Discovery of Potent Antimycobacterial Agents Targeting Lumazine Synthase (RibH) of Mycobacterium tuberculosis. Singh, M., A. Dhanwal, A. Verma, L. Augustin, N. Kumari, S. Chakraborti, N. Agarwal, D. Sriram, and R.J. Dey. Scientific Reports, 2024. 14(1): p. 12170. PMID[38806590]. PMCID[PMC11133327].
[PubMed]. TB_05_2024.

15. Facile Green Synthesis of Silver Nanoparticles Derived from the Medicinal Plant Clerodendrum serratum and its Biological Activity Against Mycobacterium Species. Vidyasagar, R.R. Patel, S.K. Singh, D. Dehari, G. Nath, and M. Singh. Heliyon, 2024. 10(10): p. e31116. PMID[38799742]. PMCID[PMC11126841].
[PubMed]. TB_05_2024.

16. Computational Drug Repositioning Identifies Niclosamide and Tribromsalan as Tnhibitors of Mycobacterium Tuberculosis and Mycobacterium Abscessus. Yang, J.J., A. Goff, D.J. Wild, Y. Ding, A. Annis, R. Kerber, B. Foote, A. Passi, J.L. Duerksen, S. London, A.C. Puhl, T.R. Lane, M. Braunstein, S.J. Waddell, and S. Ekins. Tuberculosis, 2024. 146: p. 102500. PMID[38432118]. PMCID[PMC10978224].
[PubMed]. TB_05_2024.

Patent Citations

17. Antibacterial compounds. Bartolome-Nebreda, J. M., M. L. Martin-Martin, D. A. Lamprecht, B. H. T. Stoops, K. I. E. Amssoms and G. A. F. Verniest. Patent. 2024. WO2023-EP799232024089170: 270pp.
[Patent]. TB_05_2024.

18. (6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents. Venugopala, K. N., K. M. Bairagi, P. K. Deb, M. Pillay, M. A. Morsy, S. K. Nayak, S. Chandrashekharappa, and O. I. Alwassil. Patent. 2024. US2023-36763511986476: 14 pp.
[Patent]. TB_05_2024.

19. Preparation of 3-cyano-4,5-diphenylfuran-2-carboxamides as antitubercular agents. Venugopala, K. N., P. K. Deb and R. P. Mailavaram. Patent. 2024. US2023-37111011987563: 11pp.
[Patent]. TB_05_2024.

20. Oxoimidazolidine derivatives as anti-tubercular agents. Venugopala, K. N., P. K. Deb, M. Pillay, N. P, M. A. Morsy, S. S, J. P. Dasappa, and R. Venugopala. Patent. 2024. US2023-37567211981643: 18pp.
[Patent]. TB_05_2024.

21. Substituted 7-amino-3-(substituted benzoyl)indolizine-1-carboxylates as anti-tubercular agents and their preparation. Venugopala, K. N., M. Pillay, V. Uppar, P. K. Deb, R. Venugopala, S. Chandrashekharappa and B. Padmashali. Patent. 2024. US2023-38282911976066: 13pp.
[Patent]. TB_05_2024.

22. Substituted 7,8-dihydropyrimido[4,5-d]pyrimidines as anti-tubercular agents and their preparation. Venugopala, K. N., R. Venugopala, M. Pillay, V. Kamat and A. Kumar. Patent. 2024. US2023-50850311976076: 12pp.
[Patent]. TB_05_2024.